Denosumab
Also called: Prolia
What it means
Denosumab (Prolia) is a twice-yearly injection that blocks RANKL, a signal osteoclasts need to mature, slowing bone breakdown.
Because its effect disappears once stopped, understanding how denosumab works helps you and your doctor plan carefully to avoid rebound fracture risk.
Denosumab, sold under the brand name Prolia, is a twice-yearly injection for osteoporosis. It works by blocking RANKL, a signal that tells osteoclast precursor cells to mature into active bone-removing cells. By interrupting this signal, denosumab is an antiresorptive drug: it slows the breakdown side of bone remodeling so that bone-building can get ahead. It's been shown to reduce fracture risk substantially in trials.
There's one thing about denosumab that sets it apart from bisphosphonates: it doesn't stay stored in bone. That means its effect wears off as soon as the drug is stopped. Stopping without moving to another medication has been linked to a rapid rebound in bone turnover and a risk of multiple vertebral fractures, sometimes within just months. This pattern is well documented in clinical research and guidelines.
If you're on Prolia, the key takeaway is that missing a dose or stopping on your own isn't a neutral decision. Any changes to this medication, including timing or discontinuation, should be discussed with your prescriber, who can help plan a safe transition if one is needed.
How sure is this?
Graded Strong Clinical Evidence: Supported by multiple well-designed clinical studies in humans. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.
Where the Academy teaches it
This page is the short version. The lessons teach it in full, with the context around it and a quiz to lock it in.
Questions people ask about this
Bone medications generally work in one of two ways: they either slow down the cells that break down old bone (antiresorptives), or they actively stimulate the cells that build new bone (anabolics). Which family your drug belongs to tells you a lot about what it can realistically do, and that's worth asking your prescriber about directly.
Read the full answer →That's a decision for you and your prescriber, not something OsteoStrong changes. Medication and mechanical loading work on different parts of the same system — your drug manages the chemical signalling of bone remodeling, while loading supplies a mechanical stimulus along with muscle, balance and coordination. They're meant to work alongside each other, not replace one another.
Read the full answer →Stopping Prolia (denosumab) isn't a neutral event. Because it doesn't build up in your bones the way bisphosphonates do, its protective effect wears off once doses stop. This can lead to a rapid rebound in bone turnover and a risk of multiple vertebral fractures, sometimes within months — so this is a decision to make with your prescriber, not on your own.
Read the full answer →Related words
Antiresorptive medications, like bisphosphonates and denosumab, slow down the cells that break down old bone,…
RANKL is a signal that activates osteoclasts, the cells that break down bone, and it's a key target for some…
Bisphosphonates are osteoporosis medications — like alendronate, risedronate, and zoledronic acid — that slow down…
Osteoclasts are the cells that break down old bone tissue, working alongside bone-building osteoblasts to constantly…
A fragility fracture is a broken bone caused by a fall or bump that normally wouldn't break a healthy bone, often at…
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.
